about
Parkinson's disease tremor-related metabolic network: characterization, progression, and treatment effectsMovement preparation and bilateral modulation of beta activity in aging and Parkinson's disease.Tor1a+/- mice develop dystonia-like movements via a striatal dopaminergic dysregulation triggered by peripheral nerve injury.Enhanced catecholamine transporter binding in the locus coeruleus of patients with early Parkinson disease.Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.The influence of dopaminergic striatal innervation on upper limb locomotor synergies.Gait initiation in children with Rett syndrome.Influence of CT-based attenuation correction on dopamine transporter SPECT with [(123)I]FP-CIT.Mechanical Energy Recovery during Walking in Patients with Parkinson Disease.Loss of thalamic serotonin transporters in early drug-naïve Parkinson's disease patients is associated with tremor: an [(123)I]beta-CIT SPECT study.Finding a new therapeutic approach for no-option Parkinsonisms: mesenchymal stromal cells for progressive supranuclear palsyNeuromelanin Imaging and Dopaminergic Loss in Parkinson's DiseaseSingle photon-emission computed tomography imaging in early Parkinson's disease.Striatal Dopaminergic Innervation Regulates Subthalamic Beta-Oscillations and Cortical-Subcortical Coupling during Movements: Preliminary Evidence in Subjects with Parkinson's Disease.Autologous mesenchymal stem cell therapy for progressive supranuclear palsy: translation into a phase I controlled, randomized clinical study.Beta Oscillatory Changes and Retention of Motor Skills during Practice in Healthy Subjects and in Patients with Parkinson's Disease.Pallidal deep brain stimulation for primary dystonia in children.Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study.Mucuna pruriens for Parkinson's disease: Low-cost preparation method, laboratory measures and pharmacokinetics profile.Progressive gait ataxia following deep brain stimulation for essential tremor: adverse effect or lack of efficacy?Dementia in Parkinson's disease: Is male gender a risk factor?Cholinergic activity and levodopa-induced dyskinesia: a multitracer molecular imaging study.Striatal dopamine transporter binding in patients with Parkinson's disease and severe occupational hydrocarbon exposure.Reply: Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.Night-time use of rotigotine in advanced Parkinson's disease.Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's disease.Imaging essential tremor.Parkinson's disease beyond 20 years.Factors predicting protracted improvement after pallidal DBS for primary dystonia: the role of age and disease duration.Swallowing disturbances in Parkinson's disease: a multivariate analysis of contributing factors.Imaging evidence supports a link between essential tremor and Parkinson's disease.Functional abnormalities underlying pathological gambling in Parkinson disease.Monoamine transporter availability in Parkinson's disease patients with or without depression.[123I]FP-CIT SPET imaging in drug-induced Parkinsonism.Predictive value of nigrostriatal dysfunction in isolated tremor: a clinical and SPECT study.Artistic productivity and creative thinking in Parkinson's disease.A voxel-based PET study of dopamine transporters in Parkinson's disease: relevance of age at onset.Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease.Striatal dopamine transporter abnormalities in patients with essential tremor.The relationship between impulsivity and impulse control disorders in Parkinson's disease.
P50
Q24631118-4BD3BFBC-D487-47CC-9EDE-36204F678916Q30418885-6BEB7394-20BA-47AA-8E88-B6D7D1B2C3FFQ30818559-37DC2CF1-8D0A-4EE3-9641-31F2FD0003A0Q33967306-081759D8-813D-4FEF-A945-50E9563B449FQ34044060-75D908E8-DCA0-4DB3-A924-71E63F8622ABQ34511022-B728C187-7240-469E-A8B5-610D8C6E9C8CQ35151610-469895AF-BEDB-4C7A-A4D4-1249CF8A1DFFQ35656604-28B77A04-75A0-4F25-B535-550DEDC20B43Q36039924-72710213-72EE-4A84-A5BF-1A39F0CDC95BQ36738260-F9C50DAE-2DCE-4D1B-A134-68AB73C1CF55Q36886627-3E953FA7-9AF9-4DCC-BBA7-DED2B4083BB3Q37192855-769E384A-F510-4F24-A98B-AD0435BBCC1BQ37352055-1954E3FA-D5AB-4236-9B37-52D62352DEFEQ37475076-2366E05A-7ED5-4F3F-B421-8D00EA2939AEQ37550552-A3778DDD-5F98-4C4D-8F02-768ABDC96388Q37683163-4709EABD-153D-48F4-86C8-776AD93BA556Q37821728-44F6E92D-F911-4862-B276-8CE65D44DF73Q38374505-F3D184B3-4EAE-4BCA-BA21-EA9CED4775A7Q38933963-D26571B7-1872-4997-AC1C-4C65C30943D2Q39361816-648BF66E-4A8F-4A27-B937-19E92DBF7A23Q40866730-5D111918-A86C-4FEE-B332-180B205EDB5EQ41510167-890833D6-6032-4004-A6C2-42B3FBE12A43Q42169088-59B91587-1135-4EBE-8C7A-9577EEB91902Q42592792-AF807762-C696-4CF5-B768-4ECF1BD2FBA9Q42746622-7762AB60-FA7E-4AC2-8092-DD9E54EE39E8Q42789671-CE1D1F66-78E4-4318-9796-7B58A37FA498Q43076413-6B890CF8-A923-4651-8B52-65C84C25FFBEQ43815096-223D6FF6-4DC3-48CD-95EF-F41080E4E34CQ43923139-E883D9E7-638B-47DD-BE09-798A73C2516CQ45065251-EBFF9915-0C84-43C4-ABA3-229B37983D60Q46133060-C4004243-8DE0-486D-8544-E2DF3A89D9CBQ46209391-B39A1100-EBE3-4FC4-A959-1E63E1719E0DQ46226006-AF2385C0-4C0D-4AE7-9C21-F5D68B1FB423Q46401804-93C35701-FA84-49EE-9E20-32316F9259DDQ46401838-BE641CE0-5061-4F33-BBC1-B965EEEC14C5Q46563951-D743283E-DE99-4843-B6C7-0767460DED69Q46575983-CCC218BE-32F7-4FB1-9A7D-83E957BCD057Q46716788-2E07FA22-B1B3-4E46-BF19-C5F42E91E1CFQ46720765-25215CA0-E511-4514-9D3F-2A313AADBF80Q46860166-3D75A861-A191-4477-9CFA-1BFD907B910E
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Ioannis Isaias
@ast
Ioannis Isaias
@en
Ioannis Isaias
@es
Ioannis Isaias
@nl
Ioannis Isaias
@sl
type
label
Ioannis Isaias
@ast
Ioannis Isaias
@en
Ioannis Isaias
@es
Ioannis Isaias
@nl
Ioannis Isaias
@sl
altLabel
Ioannis U Isaias
@en
Ioannis U. Isaias
@en
Ioannis Ugo Isaias
@en
Isaias IU
@en
prefLabel
Ioannis Isaias
@ast
Ioannis Isaias
@en
Ioannis Isaias
@es
Ioannis Isaias
@nl
Ioannis Isaias
@sl
P214
P1053
F-4492-2014
P106
P1153
8560608500
P21
P214
P2798
P31
P3829
P3835
ioannis-isaias
P4012
P496
0000-0002-3552-5144
P734
P735
P7859
viaf-50329004